Form D · Biotechnology
Moberg Analytics Inc
Philadelphia, PA · CIK 0002093765
Offering snapshot reported Oct 29, 2025 · SEC filing
- Reported sold
- $600K Offering amount: $2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 20, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2025 | Initial | $600,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562384
Source: Form D, filed Oct 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard S. Moberg | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
109 S. 13 Th St. Unit 2 South
Philadelphia, PA, 19107
Philadelphia, PA, 19107